Published in Clin Exp Immunol on June 01, 1976
Mechanisms involved in protection provided by immunization against core lipopolysaccharides of Escherichia coli J5 from lethal Haemophilus pleuropneumoniae infections in swine. Infect Immun (1986) 1.22
Circulating immune complexes in syphilitic nephropathy. A case report. Br J Vener Dis (1978) 1.03
Antitreponemal IgE in early syphilis. Br J Vener Dis (1980) 0.85
Changes in intravascular kininogen during the Jarisch-Herxheimer reaction in secondary syphilis. Br J Vener Dis (1982) 0.79
Jarisch-Herxheimer reaction in complement-depleted rabbits. Histological and immunofluorescence studies of early cutaneous lesions. Br J Vener Dis (1981) 0.79
Changes in intravascular complement, kininogen, and histamine during Jarisch-Herxheimer reaction in secondary syphilis. Genitourin Med (1985) 0.75
Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry (1965) 96.68
ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS. Anal Biochem (1965) 24.93
Diagnostic complement fixation. I. A method. Am J Syph Gonorrhea Vener Dis (1952) 7.02
Precipitin reactions of the C1q component of complement with aggregated gamma-globulin and immune complexes in gel diffusion. Immunology (1970) 6.89
The complement system of man. I. N Engl J Med (1972) 3.09
Evidence for circulating immune complexes in lepromatous leprosy. Lancet (1972) 1.94
TOTAL HEMOLYTIC COMPLEMENT (CH50) AND SECOND COMPONENT OF COMPLEMENT (C2 HU) ACTIVITY IN SERUM AND SYNOVIAL FLUID. Arthritis Rheum (1965) 1.67
Evidence for circulating immune complexes in thyroid disease. Br Med J (1974) 1.15
Plasma kinin formation by complexes of aggregated gamma-globulin and serum proteins. Br J Exp Pathol (1970) 1.06
Effects on serum complement of normal and pre-eclamptic pregnancy and of oral contraceptives. Br J Exp Pathol (1975) 0.91
Ensembl 2009. Nucleic Acids Res (2008) 25.38
Ensembl 2008. Nucleic Acids Res (2007) 20.67
Ensembl 2007. Nucleic Acids Res (2006) 20.10
Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel. JAMA (2000) 7.81
Prevalence of antibodies to human immunodeficiency virus, gonorrhoea rates, and changed sexual behaviour in homosexual men in London. Lancet (1987) 7.71
Diversity in the practice of district ethics committees. BMJ (1989) 7.54
Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients. Nature (1985) 6.65
Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain. Lancet (1984) 5.20
Slim disease: a new disease in Uganda and its association with HTLV-III infection. Lancet (1985) 4.99
The epic project: developing national evidence-based guidelines for preventing healthcare associated infections. Phase I: Guidelines for preventing hospital-acquired infections. Department of Health (England). J Hosp Infect (2001) 4.95
Mortality effects of community socioeconomic status. Epidemiology (1997) 4.82
Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC). J Infect Dis (1995) 4.60
Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel. JAMA (1998) 4.42
Use of aspirin by general practitioners in suspected acute myocardial infarction. BMJ (1994) 4.12
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet (1996) 4.05
Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity. Lancet (1990) 4.01
A randomised controlled trial of a new handheld vacuum extraction device. BJOG (2005) 3.48
Antibody capture radioimmunoassay for anti-rubella IgM. J Hyg (Lond) (1981) 3.38
Australia antigen and antibody among patients attending a clinic for sexually transmitted diseases. Lancet (1973) 3.04
A novel lymphotropic herpesvirus. Lancet (1987) 2.89
Decision analysis in medicine. BMJ (1992) 2.88
Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. AIDS (1997) 2.88
Estimation of incidence and recovery rates of Plasmodium falciparum parasitaemia from longitudinal data. Bull World Health Organ (1976) 2.56
Hepatitis C virus: evidence for sexual transmission. BMJ (1991) 2.50
Failure to deliver hepatitis B vaccine: confessions from a genitourinary medicine clinic. BMJ (1991) 2.49
Human immunodeficiency virus infection in two cohorts of homosexual men: neutralising sera and association of anti-gag antibody with prognosis. Lancet (1987) 2.34
Tick-borne encephalitis virus - a review of an emerging zoonosis. J Gen Virol (2009) 2.32
The General Medical Council's Performance Procedures: peer review of performance in the workplace. Med Educ (2001) 2.27
Acute encephalopathy coincident with seroconversion for anti-HTLV-III. Lancet (1985) 2.26
The assessment of poorly performing doctors: the development of the assessment programmes for the General Medical Council's Performance Procedures. Med Educ (2001) 2.26
Detection of herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reaction. J Med Virol (1992) 2.22
Detection of human herpesvirus 8 DNA in semen from HIV-infected individuals but not healthy semen donors. AIDS (1997) 2.20
Dopamine agonists reorient visual exploration away from the neglected hemispace. Neurology (1998) 2.18
Feminizing genitoplasty for congenital adrenal hyperplasia: what happens at puberty? J Urol (1999) 2.17
Prediction of progression to AIDS with serum HIV-1 RNA and CD4 count. Lancet (1995) 2.17
Contrasting patterns and frequency of antibodies to the surface, core, and e antigens of hepatitis B virus in blood donors and in homosexual patients. J Med Virol (1981) 2.16
The UK blood transfusion service: over a (patent) barrel? Lancet (2002) 2.15
Human herpesvirus 6 in salivary glands. Lancet (1990) 2.15
A microtitre format point mutation assay: application to the detection of drug resistance in human immunodeficiency virus type-1 infected patients treated with zidovudine. J Med Virol (1992) 2.15
Surgical abortion at twenty weeks: is morality determined solely by the outcome? J Med Ethics (1989) 2.13
Leucocyte migration and cell-mediated immunity in syphilis. Br J Vener Dis (1972) 2.12
Prevalence of maternal HIV infection based on unlinked anonymous testing of newborn babies. Lancet (1990) 2.11
Birthing pools and infection control. Lancet (1996) 2.09
Human T-lymphotropic virus type III (HTLV-III) infection in seronegative haemophiliacs after transfusion of factor VIII. Lancet (1985) 2.08
Abnormal haemoglobins in the Sudan savanna of Nigeria. I. Prevalence of haemoglobins and relationships between sickle cell trait, malaria and survival. Ann Trop Med Parasitol (1979) 2.07
Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London. BMJ (1993) 2.07
The production of monoclonal antibodies to rubella haemagglutinin and their use in antibody-capture assays for rubella-specific IgM. J Hyg (Lond) (1982) 2.02
A collagen disorder of the nervous system presenting as multiple sclerosis. Brain (1972) 2.00
Life support in the intensive care unit: a qualitative investigation of technological purposes. Canadian Critical Care Trials Group. CMAJ (1999) 1.95
The alpha and beta errors in randomized trials. N Engl J Med (1990) 1.94
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. HIV Med (2003) 1.94
TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers. Neurology (2010) 1.93
"Risk" factors affecting readmission of the elderly into the health care system. Med Care (1986) 1.90
Human immunodeficiency viruses in patients attending a sexually transmitted disease clinic in London, 1982-7. BMJ (1989) 1.89
Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre. AIDS (2001) 1.86
Cleavage stage versus blastocyst stage embryo transfer in assisted conception. Cochrane Database Syst Rev (2007) 1.78
Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol (1996) 1.75
Are many women immunized against rubella unnecessarily? J Hyg (Lond) (1981) 1.75
A longitudinal study of human malaria in the West African Savanna in the absence of control measures: relationships between different Plasmodium species, in particular P. falciparum and P. malariae. Am J Trop Med Hyg (1980) 1.73
Copper content in Areca catechu (betel nut) products and oral submucous fibrosis. Lancet (1997) 1.71
Characterization of monoclonal antibodies against the human immunodeficiency virus (HIV) gag products and their use in monitoring HIV isolate variation. J Gen Virol (1987) 1.71
HIV results in the frame. Results confirmed. Nature (1995) 1.69
Demonstration of viraemia patterns in haemophiliacs treated with hepatitis-C-virus-contaminated factor VIII concentrates. Lancet (1990) 1.69
Direct measurement of viraemia in patients infected with HIV-1 and its relationship to disease progression and zidovudine therapy. J Med Virol (1991) 1.68
HIV-1 RNA serum-load and resistant viral genotypes during early zidovudine therapy. Lancet (1995) 1.67
Age prevalence of antibody to human herpesvirus 6. Lancet (1988) 1.66
Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy. AIDS (1999) 1.65
Detection by PCR of HHV-6 and EBV DNA in blood and oropharynx of healthy adults and HIV-seropositives. Lancet (1990) 1.64
Array-based DNA methylation profiling in follicular lymphoma. Leukemia (2009) 1.63
A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. Am J Surg (2000) 1.62
The generation of diversity in phosphorylcholine-binding antibodies. Adv Immunol (1984) 1.59
Hyperactive children as teenagers: a follow-up study. J Nerv Ment Dis (1971) 1.59
Real-time PCR quantitation of hepatitis B virus DNA using automated sample preparation and murine cytomegalovirus internal control. J Virol Methods (2005) 1.57
Development of an enzyme-linked immunosorbent assay (ELISA) for hepatitis B e antigen and antibody. J Virol Methods (1981) 1.57
HBV DNA levels and transmission of hepatitis B by health care workers. J Clin Virol (2003) 1.54
An inhibitor of the toxicity of tumour necrosis factor in the serum of patients with sarcoidosis, tuberculosis and Crohn's disease. Clin Exp Immunol (1990) 1.53
Incidence of HIV infection in homosexual men in London, 1988-94. BMJ (1995) 1.52
Establishment and characterisation of cell lines from patients with lung cancer (predominantly small cell carcinoma). Br J Cancer (1985) 1.52
Cadaveric renal transplantation. Lancet (1967) 1.52
The effect of smoking on the late patency of arterial reconstructions in the legs. Br J Surg (1978) 1.51
Development of a real-time, TaqMan reverse transcription-PCR assay for detection and differentiation of lyssavirus genotypes 1, 5, and 6. J Clin Microbiol (2005) 1.49
Surveillance for West Nile virus in British birds (2001 to 2006). Vet Rec (2008) 1.47
Adult T-cell leukaemia/lymphoma in Brazil and its relation to HTLV-I. Lancet (1990) 1.47
Changing patterns in the humoral immune response to malaria before, during, and after the application of control measures: a longitudinal study in the West African savanna. Bull World Health Organ (1978) 1.47
Rubella-specific IgM reactivity in sera from cases of infectious mononucleosis. J Hyg (Lond) (1983) 1.45
A new method for measuring menstrual blood loss and its use in screening women before endometrial ablation. Br J Obstet Gynaecol (1996) 1.45
Outbreak of hepatitis A in an extended family after importation by non-immune travellers. Epidemiol Infect (2011) 1.45
Oral lesions and conditions associated with human immunodeficiency virus infection in 1000 South Indian patients. Ann Acad Med Singapore (2004) 1.44
The mitochondrial permeability transition pore. Biochem Soc Symp (1999) 1.43
Effect of four different types of single-dose treatment with chloroquine and with chloroquine and pyrimethamine on Plasmodium falciparum infections in a semi-immune population in northern Nigeria. Bull World Health Organ (1972) 1.41
Vitreous fluid sampling and viral genome detection for the diagnosis of viral retinitis in patients with AIDS. J Med Virol (1994) 1.39
Advanced medical courses at the Royal Society of Medicine. J R Soc Med (1991) 1.39
A low cost spacer device used for asthma treatment in a Calcutta street clinic to improve efficacy of metered dose inhalers. Trop Doct (1998) 1.39
The structure and genetics of mouse immunoglobulins: an analysis of NZB myeloma proteins and sets of BALB/c myeloma proteins binding particular haptens. Cold Spring Harb Symp Quant Biol (1977) 1.38